Fever is NOT a defining feature of tumor lysis syndrome
Fever is not part of the diagnostic criteria for tumor lysis syndrome, which is defined by specific metabolic derangements (hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia) and their clinical consequences (renal failure, cardiac arrhythmias, seizures). 1, 2
Understanding TLS Definition
TLS is characterized by a group of metabolic abnormalities caused by massive cellular lysis, not by fever 1. The syndrome is classified into:
- Laboratory TLS: At least 2 biochemical abnormalities (hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia)
- Clinical TLS: Laboratory TLS plus clinical manifestations (acute kidney injury, cardiac arrhythmias, seizures, death)
The Relationship Between Fever and TLS
While fever is not a diagnostic criterion, there are important clinical nuances:
Fever as a Potential Trigger
- One case report documented TLS occurring after a sustained high fever (42.0°C) in a patient with high-grade lymphoblastic lymphoma 3
- A recent pediatric case showed fever developing after laparoscopic biopsy, which then progressed to TLS 4
- These represent rare exceptions where fever may have triggered tumor lysis, not a typical association
Clinical Context
When fever occurs in patients with TLS, consider:
- Concurrent infection/sepsis (which is a separate complication)
- Underlying malignancy causing constitutional symptoms
- Post-procedure fever in cases of spontaneous TLS following biopsies
Key Clinical Pitfall
Do not wait for fever to diagnose or treat TLS. The focus should be on:
- Monitoring electrolytes (potassium, phosphate, calcium, uric acid) every 12 hours in high-risk patients 2
- Recognizing metabolic derangements early
- Implementing prevention strategies (hydration, rasburicase for high-risk patients) 1, 2
The presence or absence of fever should not influence your risk stratification or management decisions for TLS. Base these decisions on tumor burden, proliferation rate, chemosensitivity, and baseline metabolic parameters.